Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

Những quyển sách tương tự

• In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
  Bằng: Mascio, Carmela T. M., et al.
  Được phát hành: (2012)
• In Vitro Activities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
  Bằng: Citron, Diane M., et al.
  Được phát hành: (2012)
• Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates
  Bằng: Goldstein, Ellie J. C., et al.
  Được phát hành: (2013)
• In Vitro Activity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
  Bằng: Snydman, David R., et al.
  Được phát hành: (2011)
• Activity of Ceftolozane-Tazobactam against a Broad Spectrum of Recent Clinical Anaerobic Isolates
  Bằng: Snydman, David R., et al.
  Được phát hành: (2014)